This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2015 Oct;42(7):939-40.

doi: 10.1111/apt.13335.

Letter: infliximab de-escalation based on trough levels in patients with inflammatory bowel disease

S Paul¹, X Roblin², L Peyrin-Biroulet³

Affiliations

Affiliations

¹ Laboratoire d'Immunologie et d'Immunomonitoring, CIC INSERM 1408 Vaccinologie, GIMAP EA3064, CHU de Saint-Etienne, Saint-Etienne, France.
² Service de Gastrologie-Entérologie-Hépatologie, CHU de Saint-Etienne, Saint-Etienne, France. xavier.roblin@chu-st-etienne.fr.
³ Inserm U954 and Department of Gastroenterology, Nancy University Hospital, Henri Poincaré University, Vandoeuvre-lès-Nancy, France.

PMID: 26331560
DOI: 10.1111/apt.13335

Comment

Letter: infliximab de-escalation based on trough levels in patients with inflammatory bowel disease

S Paul et al. Aliment Pharmacol Ther. 2015 Oct.

. 2015 Oct;42(7):939-40.

doi: 10.1111/apt.13335.

Authors

S Paul¹, X Roblin², L Peyrin-Biroulet³

Affiliations

¹ Laboratoire d'Immunologie et d'Immunomonitoring, CIC INSERM 1408 Vaccinologie, GIMAP EA3064, CHU de Saint-Etienne, Saint-Etienne, France.
² Service de Gastrologie-Entérologie-Hépatologie, CHU de Saint-Etienne, Saint-Etienne, France. xavier.roblin@chu-st-etienne.fr.
³ Inserm U954 and Department of Gastroenterology, Nancy University Hospital, Henri Poincaré University, Vandoeuvre-lès-Nancy, France.

PMID: 26331560
DOI: 10.1111/apt.13335

No abstract available

PubMed Disclaimer

Comment in

Letter: infliximab de-escalation based on trough levels in patients with inflammatory bowel disease - authors' reply.
Chaparro M, Gisbert JP. Chaparro M, et al. Aliment Pharmacol Ther. 2015 Oct;42(7):940-1. doi: 10.1111/apt.13368. Aliment Pharmacol Ther. 2015. PMID: 26331561 No abstract available.

Comment on

Systematic review: factors associated with relapse of inflammatory bowel disease after discontinuation of anti-TNF therapy.
Gisbert JP, Marín AC, Chaparro M. Gisbert JP, et al. Aliment Pharmacol Ther. 2015 Aug;42(4):391-405. doi: 10.1111/apt.13276. Epub 2015 Jun 15. Aliment Pharmacol Ther. 2015. PMID: 26075832

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information